Ray Sumita
Chief Legal Compliance Officer
Ray Sumita has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.
On the most recent filing, Ray Sumita is listed as Chief Legal Compliance Officer at Cue Biopharma, Inc. Inside the rolling window, Ray Sumita reported no open-market purchases and 2 open-market sales totaling $317K in CUE. The largest disclosed transaction in the window is a sale of 8,829 CUE shares on Aug 13, 2026, worth $266K.
Companies traded
Other insiders at CUE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$317K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ray Sumita made?
Ray Sumita has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Ray Sumita trade?
Ray Sumita has filed SEC Form 4 disclosures for 1 company, including CUE.
When was Ray Sumita's most recent SEC Form 4 filing?
Ray Sumita's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.
What is Ray Sumita's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ray Sumita is listed as Chief Legal Compliance Officer.
What is Ray Sumita's total buy and sell value in the current window?
Inside the rolling retention window, Ray Sumita bought $0 and sold $317K based on SEC Form 4 filings.
What was Ray Sumita's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,829 CUE shares on 2026-08-13, worth $266K, per SEC Form 4 filings.